Communication to Pharmacies: General

• Guía operacional sobre el despacho de medicamentos durante el estado de emergencia debido al COVID-19
  March 2020
• Entrega de medicamentos durante el estado de emergencia debido al COVID-19 y la Ley Núm. 19-2020
  Marzo 2020
• Despacho de Medicamentos en Situaciones de Emergencia y/o durante Estado de Emergencia – Poveedores Puerto Rico
  Marzo 2020
• Comunicado para proveedores sobre Emergencia COVID-19
  Marzo 2020
• RE: Carta Normativa ASES 19-0305. Política pública de anti-discrimen a beneficiarios por razón de identidad de género, expresión de género u orientación sexual real o percibida, al solicitar o recibir servicios de salud.
  Marzo 2019
• RE: ASES Normative Letter 19-0305. Public policy for non-discrimination to beneficiaries by reason of gender identity, expression of gender or real or perceived sexual orientation, when requesting or receiving health services.
  March 2019
• Guía Básica a Proveedores para manejo sensible y adecuado al brindar servicios de salud a beneficiarios LGBTT+
  March 2019
• Importance of the credentialization of pharmacies – Puerto Rico
  February 2019

Communication to Pharmacies: Safety

• Ranitidine All Products Safety Communication
  April 2020
• EpiPen: Drug Safety Communication
  March 2020
• FDA advises patients on use of NSAIDs for COVID-19
  March 2020
• Montelukast: Drug Safety Communication
  March 2020
• Clozapine: Drug Safety Communication
  February 2020
• Rituxan: Drug Safety Communication
  January 2020
• Ibrance, Kisqali and Verzenio: Drug Safety Communication
  October 2019
• Mavyret™, Zepatier™, and Vosevi™: Drug Safety Communication
  September 2019

• Uloric: Drug Safety Communication
  March 2019
• Tofacitinib: Drug Safety Communication Update
  February 2019

Communication to Pharmacies: Education

• Coronavirus and Hand Sanitizers
  April 2020
• Emergency use authorization of medications for certain patients with COVID-19
  April 2020
• Potential COVID-19 Treatment Hydroxychloroquine: Access and Safety
  March 2020
• New indications and first-time generics approved by the FDA from October 2019 to December 2019
  March 2020
• Coronavirus
  February 2020
• Update to Guidelines on Community-Acquired Pneumonia
  January 2020
• Dry Eye Disease
  December 2019
• New indications and first-time generics approved by the FDA from July 2019 to September 2019
  November 2019

• Biosimilar Products
  October 2019
• CDC, ACIP Flu Vaccine Recommendations for Upcoming Season
  September 2019
• AHA, ACC New Clinical Guidelines on Cholesterol
  August 2019
• New indications and first-time generics approved by the FDA from April 2019 to June 2019
  July 2019
• Proper use of non-prescription decongestant products.
  June 2019
• New indications and first-time generics approved by the FDA from January 2019 to March 2019
  May 2019
• Administrative Order 402 – Naloxone Sale Without Prescription
  April 2019
• Orden Administrativa 402 – Venta de Naloxona sin Receta
  Abril 2019
• No link between MMR vaccine and autism
  March 2019
• Influenza Clinical Practice Guidelines Update
  February 2019
• New indications and first time generic approved by the FDA
  January 2019
• New indications and new generic approvals from October to December 2018
  January 2019
• New indications and first-time generics approved by the FDA from July 2018 to September 2018
  October 2018
• Updated Guidelines for Resistant Hypertension
  September 2018
• Medication Disposal
  August 2018
• New indications and first-time generics approved by the FDA from January 2018 to June 2018
  July 2018
• Updates in the Guidelines for the use of Antiretroviral Agents in Adults and Adolescents Living with HIV
  June 2018
• 2017 New Drug Approvals Summary
  April 2018
• PCSK9 Inhibitors
  March 2018
• ADA 2018 Standards of Care for Diabetes
  February 2018
• New AHA-ACC High Blood Pressure Guidelines
  January 2018  

PharmNotes

• March 2020
• February 2020
• January 2020
• December 2019
• November 2019
• October 2019
• September 2019
• August 2019

• July 2019
• June 2019
• May 2019
• April 2019
• March 2019
• February 2019
• January 2019
• December 2018
• November 2018
• October 2018
• September 2018
• August 2018
• July 2018
• June 2018
• May 2018
• April 2018
• March 2018
• February 2018
• January 2018

Recalls

• Drug Recall: Ketorolac injection
  March 2020
• Drug Recall: Phenytoin Suspension
  February 2020
• Drug Recall: Rompe Pecho liq
  January 2020
• Drug Recall: Nitzatinine caps
  January 2020
• Drug Recall: Lamotrigine tabs
  January 2020
• Drug Recall: Mirtazapine tab
  January 2020